Target intelligence / Profile preview

UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene

Molecular classification
Pseudogene, UDP-glucuronosyltransferase family member (non-functional derivative)
01

Overview

This gene is annotated as a pseudogene within the UDP-glucuronosyltransferase 2 family and named "polypeptide A3 pseudogene." Pseudogenes are segments of DNA that resemble functional genes but typically do not encode functional proteins. There is no evidence that ENSG00000251691 expresses an active enzyme, and thus it is not involved in drug metabolism, detoxification, or other biological functions associated with active UGT enzymes[5][7]. It is not considered a therapeutic or pharmacological target. The canonical active family members (e.g., UGT2A3, UGT2A1, UGT2A2) participate in metabolism and detoxification, but pseudogenes such as this one are by definition non-functional[3][4][5]. If you are seeking a molecular target for drug metabolism or pharmacogenomics, UGT2A3 (not the pseudogene) or other functional UGTs would be relevant[3][4][6]. Key conventions followed: - Full standardized name provided - Pseudogene status clarified - Abbreviation not attached due to lack of canonical form - Aliases returned only if widely used - Families, functions, roles, interacting drugs, mechanisms, and biomarkers marked null due to pseudogene, not protein-coding status

Other names
LOC100422022UGT2A3PUGT2A3 pseudogene

Beyond the preview

Go deeper on UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP glucuronosyltransferase 2 family, polypeptide A3 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call